Real Issues in Treating Lung Cancer Patients
CME Monograph - October 2006
This CME activity was developed for medical oncologists, radiation oncologists, oncology nurses, and other medical professionals involved in assessing, treating, and counseling patients with lung cancer.
Program Faculty
Thomas J. Lynch, Jr. , MD Chief Oncology/ Hematology, MGH Cancer Center; Alan B. Sandler, MD, Medical Director, Thoracic Oncology Vanderbilt-Ingram Cancer Center, Paul J. Hesketh, MD, Chief, Division of Hematology Oncology Caritas St. Elizabeth's Medical Center, William F. Pirl, MD, Psychiatric Oncology Service, Massachusetts General Hospital, Kevin A. Raskin, MD, Department of Orthopedic Oncology, Massachusetts General Hospital, M. Dror Michaelson, MD, PhD, Dept of Hematology/Oncology, Massachusetts General Hospital, and Jennifer S. Temel, MD, Dept of Oncology, Massachusetts General Hospital.
The CME activity is no longer active.
Educational Objectives
- Assess issues and options for systemic chemotherapy in lung cancer patients.
- Assess issues and options for the use of antiemetics and other factors in chemotherapy support.
- Assess issues and options for treating bone complications in lung cancer.
- Assess current approaches to recognizing and treating depression and anxiety in lung cancer patients.
- Discuss palliative and hospice care referral issues and options for patients with advanced disease.
Educational Grant Support
Supported by educational grants from Genentech, MGI PHARMA, Novartis Pharmaceuticals and sanofi-aventis U.S.
Sponsorship
CME sponsorship was provided by InforMEDical Communications, Inc.
